Search results
In this review, we summarize the most recent HIV vaccine efficacy trials, clinical trials initiated within the last 3 years, and discuss prominent improvements that have been made in prophylactic HIV vaccine designs.
28 paź 2013 · In this Timeline article, we look back over the past 30 years of HIV research, providing a brief overview of some of the key milestones that have been achieved since the isolation of HIV-1...
20 gru 2023 · This Review discusses lessons learned from clinical trials of HIV-1 vaccines, current technologies that are being explored, and future considerations in the development of a safe and effective HIV-1 vaccine.
27 gru 2023 · Over the past four decades, tremendous scientific advances have translated to substantial progress in confronting the HIV epidemic; however, women—particularly women from racial and ethnic groups under-represented in research, young women, and transgender women—and gender diverse people remain disproportionately affected by HIV.
HIV is a virus that remains a major health concern and results in an infection that has no cure even after over 30 years since its discovery. As such, HIV vaccine discovery continues to be an area of intensive research.
Multiple groups developed safe and efective SARS-CoV-2 vaccines in an unprecedented timeframe of 1 year,6–8 leading to the question: why has development of an HIV-1 vaccine taken more than 40 years?
1 kwi 2024 · This editorial aims to summarize the current challenges and hopes for developing vaccines to prevent HIV infection and approaches to overcome antiretroviral drug resistance as a cure for HIV/AIDS.
